chr1-155235007-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_StrongPP5_Moderate
The NM_000157.4(GBA1):c.1599G>A(p.Trp533*) variant causes a stop gained change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000157.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GBA1 | NM_000157.4 | c.1599G>A | p.Trp533* | stop_gained | Exon 11 of 11 | ENST00000368373.8 | NP_000148.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 11
GnomAD4 exome Cov.: 9
GnomAD4 genome Cov.: 11
ClinVar
Submissions by phenotype
Gaucher disease type I Pathogenic:1
The c.1599G>A variant in GBA was absent from large population and our in-house database. This variant segregated with the non-neuronopathic Gaucher disease. The glucocerbrosidase enzyme activity was deficient. -
Gaucher disease Pathogenic:1
Variant summary: GBA c.1599G>A (p.Trp533X) results in a premature termination codon. While the variant is not expected to undergo nonsense-mediated decay, variants downstream of this position have been classified as pathogenic by our laboratory (p.Arg535Cys, p.Arg535His). The variant was absent in 176860 control chromosomes. c.1599G>A has been reported in the literature in compound heterozygous indivudals affected with Gaucher Disease including one neonatal case who carried a VUS in cis and a pathogenic variant in trans (Phetthong_2021, Lecourt_2013). At least one publication reports experimental evidence evaluating an impact on protein function, however, does not allow convincing conclusions about the variant effect (Lecourt_2013). The following publications have been ascertained in the context of this evaluation (PMID: 23935976, 34930372). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at